Multiple Myeloma Training for Physicians 2018

Size: px
Start display at page:

Download "Multiple Myeloma Training for Physicians 2018"

Transcription

1 Multiple Myeloma Training for Physicians 2018 Objective and Aim: The National University Cancer Institute, Singapore (NCIS) is the only public cancer centre in Singapore treating both paediatric and adult cancers in one facility. At the NCIS, Every Person Matters and our goal is to provide comprehensive yet personalised care for each and every patient incorporating cancer awareness, prevention, diagnosis, treatment, rehabilitation and palliative care. We are featured as a one-stop facility with all essential services under one roof accessible for our patients. To ensure sustainability of our anti-cancer efforts, we are heavily involved in training the next generation of cancer warriors to front the fight against cancer. One of our key missions lies in the education, training and mentoring of the next generation of healthcare professionals in this field of medicine. As part of this important mission, we are very honoured to conduct the Multiple Myeloma Physicians Training from the 3 rd to 7 th September The workshop will be committed to presenting high quality academic content, sharing about Multiple Myeloma Disease Assessment Techniques and Implications, Diagnosis and Stratification and Treatment Plans.

2 Multiple Myeloma Training for Physicians to 7 September 2018 DAY ONE - Monday, 3 September Session 1 : Biology 9.30am 9.45am 10.45am 11.15am 12.15pm Welcome and Course Introduction Genetics / Pathways Immunology Epidemiology Session 2 : Disease Assessment Techniques and Implications 1.30pm 2.15pm 2.45pm 3.15pm 3.45pm 4.15pm Detection of Monoclonal Immunoglobulins Clinical Utility of Light and Heavy Chain Assays Monitoring and Defining Response Genomics Cyto and FISH Clinical Implications of Genomics 5.00pm End of Day 1

3 DAY TWO - Tuesday, 4 September Session 1 : Disease Assessment Techniques and Implications (con t) 9.30am 10.00am 10.30am Flow MRD Radiological Assessment Clinical implications Session 2 : Diagnosis and Stratification 11.30am 12.00nn 12.30pm 1.00pm Diagnosis Risk Stratification Case Discussion (Diagnosis) Session 3 : Treatment of Newly Diagnosed Transplant Eligible Patients 2.00pm 2.30pm 3.00pm Induction Treatment Role of Auto Transplantation Role of Consolidation Case Discussion (3 4 cases) 5.00pm End of Day 2

4 DAY THREE - Wednesday, 5 September Session 1 : Controversial Areas in Myeloma Role of Maintenance (20 mins each) Controversy Yes or No? Controversy Which drug? Controversy Fixed duration or Continuous? 10.00am 10.30am Role of Allogeneic Transplantation Session 2 : Treatment of Newly Diagnosed Non-Transplant Eligible Patients 12.00nn 1.00pm Treatment Choice and Consideration Case Studies Session 3 : Treatment of Relapse Disease 2.00pm 4.30pm Clinical Consideration and Drug Sequences Case Studies Hospital and Lab Tour 5.30pm End of Day 3

5 DAY FOUR - Thursday, 6 September Session 1 : Supportive Care 9.30am Role of Radiation Therapist Myeloma Bone Disease (30 mins each) Biology of Myeloma Bone Disease Surgical Treatment of Myeloma Bone disease Role of Bone Modulating Drug 11.30am 12.00nn 12.30pm 1.00pm Bone Health in Myeloma Patients Renal Disease in Myeloma Infection and Prevention Session 2 : Drugs used in Myeloma (Mechanism of Action and Management of Common Side Effects) 2.00pm 2.30pm 3.00pm 4.30pm Imids PIs Monoclonal Antibodies NCIS Experience with New Drugs (Ixazomib, Pom, Carfil, Dara) Case Studies (Treatment Complications, e.g. TMA with Carfilzomib, Infusion reaction with Dara) 5.00pm End of Day 4

6 DAY FIVE - Friday, 7 September Session 1 : New Treatment in Development Newer Treatment in MM Selinexor (20 mins) Venetoclax (20 mins) Immunotherapy (30 mins) 10.10am 10.30am Clinical Trial Set-up for Myeloma Session 2 : Related Plasma Cell Disorders 11.30am 12.30pm 1.30pm MGUS / SMM AL Amyloidosis Case Discussion (3 4 cases from China) Session 3 : Setting up a Good Myeloma Service 2.30pm 3.00pm 4.30pm Tumour Board and Myeloma Clinic Research Set-up Patient Centric Care Role of Advance Practice Nurse Final Summation and feedback 5.00pm End of Day 5